Free Access
Med Sci (Paris)
Volume 34, Number 2, Février 2018
Page(s) 109 - 111
Section Le Magazine
Published online 16 February 2018
  1. Mouquet H. Antibody B cell responses in HIV-1 infection. Trends Immunol 2014; 35 : 549-61. [Google Scholar]
  2. Burton D, Mascola JR. Antibody responses to envelope glycoproteins in HIV-1 infection. Nat Immunol 2015; 16 : 571-6. [Google Scholar]
  3. Caskey M, Klein F, Lorenzi JCC, et al. Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature 2015; 522 : 487-93. [Google Scholar]
  4. Peressin M, Holl V, Moog C. Les anticorps anti-VIH : de multiples activités antivirales. Med Sci(Paris) 2014; 30 : 69-75. [Google Scholar]
  5. Lynch RM, Boritz E, Coates EE, et al. Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection. Sci Transl Med 2015; 7 : 319ra206. [Google Scholar]
  6. Scheid JF, Horwitz JA, Bar-On Y, et al. HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption. Nature 2016; 535 : 556-60. [Google Scholar]
  7. Julg B, Liu PT, Wagh K, et al. Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Sci Transl Med 2017; 9 : eaao4235. [Google Scholar]
  8. Bouvin-Pley M, Morgand M, Moreau A, et al. Evidence for a continuous drift of the HIV-1 species towards higher resistance to neutralizing antibodies over the course of the epidemic. PLoS Pathog 2013; 9 : e1003477. [Google Scholar]
  9. Bournazos S, Gazumyan A, Seaman MS, et al. Bispecific anti-HIV-1 antibodies with enhanced breadth and potency. Cell 2016; 165 : 1609-20. [Google Scholar]
  10. Huang Y, Yu J, Lanzi A, et al. Engineered bispecific antibodies with exquisite HIV-1-neutralizing activity. Cell 2016; 165 : 1621-31. [Google Scholar]
  11. Xu L, Pegu A, Rao E, et al. Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques. Science 2017; 358 : 85-90. [Google Scholar]
  12. Ko SY, Pegu A, Rudicell RS, et al. Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. Nature 2014; 514 : 642-47. [Google Scholar]
  13. Ekiert DC, Friesen RHE, Bhabha G, et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 2011; 333 : 843-50. [Google Scholar]
  14. Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, et al. Recognition determinants of broadly neutralizing antibodies against dengue viruses. Nature 2015; 520 : 109-13. [Google Scholar]
  15. Kadam RU, Juraszek J, Brandenburg B, et al. Potent peptidic fusion inhibitors of influenza virus. Science 2017; 358 : 496-502. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.